Cingulate glutamate levels associate with pain in chronic pancreatitis patients

Aims: Emerging evidence show that patients with chronic pancreatitis (CP) and abdominal pain have structural and functional alterations in the central nervous system. The aim was to investigate cerebral metabolic signatures in CP and the associations to various risk factors/clinical characteristics...

Full description

Bibliographic Details
Main Authors: Tine Maria Hansen, Janusiya Anajan Muthulingam, Asbjørn Mohr Drewes, Søren Schou Olesen, Jens Brøndum Frøkjær
Format: Article
Language:English
Published: Elsevier 2019-01-01
Series:NeuroImage: Clinical
Online Access:http://www.sciencedirect.com/science/article/pii/S221315821930275X
_version_ 1819040621222952960
author Tine Maria Hansen
Janusiya Anajan Muthulingam
Asbjørn Mohr Drewes
Søren Schou Olesen
Jens Brøndum Frøkjær
author_facet Tine Maria Hansen
Janusiya Anajan Muthulingam
Asbjørn Mohr Drewes
Søren Schou Olesen
Jens Brøndum Frøkjær
author_sort Tine Maria Hansen
collection DOAJ
description Aims: Emerging evidence show that patients with chronic pancreatitis (CP) and abdominal pain have structural and functional alterations in the central nervous system. The aim was to investigate cerebral metabolic signatures in CP and the associations to various risk factors/clinical characteristics and patient outcomes. Methods: Magnetic resonance spectroscopy was used to measure brain metabolites in the anterior cingulate cortex (ACC), insula, prefrontal cortex and the parietal region in patients with CP and healthy controls. Subgroup analyses based on disease characteristics (alcoholic etiology of CP, diabetes and opioid treatment) were performed. Finally, relations to abdominal pain symptoms and quality of life scores were explored. Results: Thirty-one patients with CP (mean age 58.5 ± 9.2 years) and 23 healthy controls (54.6 ± 7.8 years) were included. Compared to healthy controls, patients had increased glutamate/creatine (glu/cre) levels in the ACC (1.24 ± 0.17 vs. 1.13 ± 0.21, p = .045) and reduced parietal N-acetylaspartate/creatine (NAA/cre) levels (1.44 ± 0.18 vs. 1.54 ± 0.12, p = .027). Patients with alcoholic etiology of CP had significant lower levels of parietal NAA/cre as compared to patients without alcoholic etiology and healthy controls (p < .006). Patients with a high level of ACC glu/cre reported more severe abdominal pain than their counterparts with a low level of ACC glu/cre (pain score 4.1 ± 2.7 vs.1.9 ± 2.3, p = .039). Conclusions: Cerebral spectroscopy revealed novel and complementary information on central pain mechanisms and alcohol mediated toxic effects in patients with CP. Our data suggest that cingulate glutamate levels associate with the patients clinical pain symptoms, while parietal NAA levels more likely associate with an alcoholic etiology of CP. Keywords: Chronic pancreatitis, Magnetic resonance imaging, Spectroscopy, Glutamate, Pain, Metabolites
first_indexed 2024-12-21T09:12:00Z
format Article
id doaj.art-ed021624ee724eb6ab8232a8301cd88b
institution Directory Open Access Journal
issn 2213-1582
language English
last_indexed 2024-12-21T09:12:00Z
publishDate 2019-01-01
publisher Elsevier
record_format Article
series NeuroImage: Clinical
spelling doaj.art-ed021624ee724eb6ab8232a8301cd88b2022-12-21T19:09:13ZengElsevierNeuroImage: Clinical2213-15822019-01-0123Cingulate glutamate levels associate with pain in chronic pancreatitis patientsTine Maria Hansen0Janusiya Anajan Muthulingam1Asbjørn Mohr Drewes2Søren Schou Olesen3Jens Brøndum Frøkjær4Mech-Sense, Department of Radiology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Søndre Skovvej 11, 9000 Aalborg, DenmarkMech-Sense, Department of Radiology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Søndre Skovvej 11, 9000 Aalborg, DenmarkDepartment of Clinical Medicine, Aalborg University, Søndre Skovvej 11, 9000 Aalborg, Denmark; Centre for Pancreatic Diseases, Department of Gastroenterology & Hepatology, Aalborg University Hospital, Mølleparkvej 4, 9000 Aalborg, DenmarkDepartment of Clinical Medicine, Aalborg University, Søndre Skovvej 11, 9000 Aalborg, Denmark; Centre for Pancreatic Diseases, Department of Gastroenterology & Hepatology, Aalborg University Hospital, Mølleparkvej 4, 9000 Aalborg, DenmarkMech-Sense, Department of Radiology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Søndre Skovvej 11, 9000 Aalborg, Denmark; Corresponding author at: Mech-Sense, Department of Radiology, Aalborg University Hospital, Hobrovej 18-22, 9000 Aalborg, Denmark.Aims: Emerging evidence show that patients with chronic pancreatitis (CP) and abdominal pain have structural and functional alterations in the central nervous system. The aim was to investigate cerebral metabolic signatures in CP and the associations to various risk factors/clinical characteristics and patient outcomes. Methods: Magnetic resonance spectroscopy was used to measure brain metabolites in the anterior cingulate cortex (ACC), insula, prefrontal cortex and the parietal region in patients with CP and healthy controls. Subgroup analyses based on disease characteristics (alcoholic etiology of CP, diabetes and opioid treatment) were performed. Finally, relations to abdominal pain symptoms and quality of life scores were explored. Results: Thirty-one patients with CP (mean age 58.5 ± 9.2 years) and 23 healthy controls (54.6 ± 7.8 years) were included. Compared to healthy controls, patients had increased glutamate/creatine (glu/cre) levels in the ACC (1.24 ± 0.17 vs. 1.13 ± 0.21, p = .045) and reduced parietal N-acetylaspartate/creatine (NAA/cre) levels (1.44 ± 0.18 vs. 1.54 ± 0.12, p = .027). Patients with alcoholic etiology of CP had significant lower levels of parietal NAA/cre as compared to patients without alcoholic etiology and healthy controls (p < .006). Patients with a high level of ACC glu/cre reported more severe abdominal pain than their counterparts with a low level of ACC glu/cre (pain score 4.1 ± 2.7 vs.1.9 ± 2.3, p = .039). Conclusions: Cerebral spectroscopy revealed novel and complementary information on central pain mechanisms and alcohol mediated toxic effects in patients with CP. Our data suggest that cingulate glutamate levels associate with the patients clinical pain symptoms, while parietal NAA levels more likely associate with an alcoholic etiology of CP. Keywords: Chronic pancreatitis, Magnetic resonance imaging, Spectroscopy, Glutamate, Pain, Metaboliteshttp://www.sciencedirect.com/science/article/pii/S221315821930275X
spellingShingle Tine Maria Hansen
Janusiya Anajan Muthulingam
Asbjørn Mohr Drewes
Søren Schou Olesen
Jens Brøndum Frøkjær
Cingulate glutamate levels associate with pain in chronic pancreatitis patients
NeuroImage: Clinical
title Cingulate glutamate levels associate with pain in chronic pancreatitis patients
title_full Cingulate glutamate levels associate with pain in chronic pancreatitis patients
title_fullStr Cingulate glutamate levels associate with pain in chronic pancreatitis patients
title_full_unstemmed Cingulate glutamate levels associate with pain in chronic pancreatitis patients
title_short Cingulate glutamate levels associate with pain in chronic pancreatitis patients
title_sort cingulate glutamate levels associate with pain in chronic pancreatitis patients
url http://www.sciencedirect.com/science/article/pii/S221315821930275X
work_keys_str_mv AT tinemariahansen cingulateglutamatelevelsassociatewithpaininchronicpancreatitispatients
AT janusiyaanajanmuthulingam cingulateglutamatelevelsassociatewithpaininchronicpancreatitispatients
AT asbjørnmohrdrewes cingulateglutamatelevelsassociatewithpaininchronicpancreatitispatients
AT sørenschouolesen cingulateglutamatelevelsassociatewithpaininchronicpancreatitispatients
AT jensbrøndumfrøkjær cingulateglutamatelevelsassociatewithpaininchronicpancreatitispatients